NCT00743262View on ClinicalTrials.gov

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

April 30, 2009

Conditions
Total Laryngectomy
Interventions
DEVICE

Provox voice prosthesis

The current voice prosthesis (Provox ActiValve)of the patients will be removed and a new prosthesis (Provox Vega) will be inserted

Trial Locations (1)

1066CX

Netherlands Cancer Institute, Amsterdam

Sponsors

Lead Sponsor

Atos Medical AB
All Listed Sponsors
collaborator

The Netherlands Cancer Institute

OTHER

lead

Atos Medical AB

INDUSTRY